Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 461
Immune Disorders Drugs 195
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 116
Endocrine and Metabolic Disorders Drugs 103
Central Nervous System Drugs 102
Drug Discovery 101
Musculoskeletal Disorders Drugs 92
Pharmaceuticals 89
Clinical Trials 89
Hematological Drugs 83
Leukemia Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 63
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 49
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 25
Bladder Cancer Drugs 24
Drugs by Therapeutic Area 23
Antibiotics 23
Kidney Cancer Drugs 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Uterine Cancer Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



286 reviews

2,373 Results (Page 83 of 119)
- Relevance
  Sort by

Anti-Inflammatory Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4136EUR$4,490USD£3,487GBP

Peptide Therapeutics Market 2024-2028

 Report
June 2024
148 Pages
Global

From

€2303EUR$2,500USD£1,941GBP

Breast Cancer Monoclonal Antibodies Market 2024-2028

 Report
July 2024
182 Pages
Global

From

€2303EUR$2,500USD£1,941GBP

Histone Deacetylase Inhibitors Market - Global Forecast 2026-2032

 Report
September 2026
189 Pages
Global

From

€3265EUR$3,545USD£2,753GBP

€3628EUR$3,939USD£3,059GBP

Multiple Sclerosis Market - Global Forecast 2026-2032

 Report
September 2026
181 Pages
Global

From

€3265EUR$3,545USD£2,753GBP

€3628EUR$3,939USD£3,059GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Parkinson's Disease Therapeutics Market - Global Forecast 2026-2032

 Report
September 2026
196 Pages
Global

From

€3265EUR$3,545USD£2,753GBP

€3628EUR$3,939USD£3,059GBP

Autoimmune Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4136EUR$4,490USD£3,487GBP

Protein Therapeutics Market 2024-2028

 Report
May 2024
191 Pages
Global

From

€2303EUR$2,500USD£1,941GBP

Non Hodgkin Lymphoma Therapeutics Market Size, Share & Trends Analysis Report By Cell Type (B-Cell Lymphoma and T-Cell Lymphoma), By Therapy Type (Radiation Therapy, Chemotherapy, Targeted Therapy, and Others), By Regional Outlook and Forecast, 2023 - 2030

 Report
January 2024
193 Pages
Global

From

€3316EUR$3,600USD£2,796GBP

Interferons Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4136EUR$4,490USD£3,487GBP

Multiple Sclerosis Therapies Market Report by Drug, Drug Type, Route of Administration, Distribution Channel, and Region 2026-2034

 Report
May 2026
137 Pages
Global

From

€3683EUR$3,999USD£3,105GBP

Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human, Humanized, Others), By Application, By Region, By Country: Market Insights and Forecast (2019-2029)

 Report
February 2024
260 Pages
Global

From

€2257EUR$2,450USD£1,903GBP

Crohn's Disease (CD) Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4136EUR$4,490USD£3,487GBP

Prostate Cancer Diagnosis and Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2024
105 Pages
Global

From

€3500EUR$4,071USD£3,054GBP

WHIM Syndrome Market - Global Forecast 2026-2032

 Report
September 2026
188 Pages
Global

From

€3265EUR$3,545USD£2,753GBP

€3628EUR$3,939USD£3,059GBP

Oral Medications for Multiple Sclerosis Market - Global Forecast 2026-2032

 Report
September 2026
183 Pages
Global

From

€3265EUR$3,545USD£2,753GBP

€3628EUR$3,939USD£3,059GBP

Neurodegenerative Diseases Market - Global Forecast 2026-2032

 Report
September 2026
188 Pages
Global

From

€3265EUR$3,545USD£2,753GBP

€3628EUR$3,939USD£3,059GBP

Global CD19 Antibody Market & Clinical Pipeline Outlook 2028

 Report
October 2023
420 Pages
Global

From

€2671EUR$2,900USD£2,252GBP

T-Cell Lymphoma Market Report: Trends, Forecast and Competitive Analysis to 2030

 Report
November 2023
150 Pages
Global

From

€4467EUR$4,850USD£3,766GBP

Thrombosis Drugs Market 2024-2028

 Report
August 2024
144 Pages
Global

From

€2303EUR$2,500USD£1,941GBP

2,373 Results (Page 83 of 119)
- 1
- 81
- 82
- 83
- 84
- 85

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.